INNOPROD MEDICAL : revenue, balance sheet and financial ratios

INNOPROD MEDICAL is a French company founded 10 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in PLAISANCE-DU-TOUCH (31830), this company of category PME shows in 2021 a revenue of 2 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - INNOPROD MEDICAL (SIREN 819008194)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C 1 750 € 34 128 € N/C N/C N/C
Net income -172 697 € -160 801 € -271 767 € -40 838 € -17 217 € -30 365 € -19 205 € -85 357 €
EBITDA -147 258 € -108 367 € -194 881 € -62 280 € -43 577 € -52 381 € -43 367 € -100 458 €
Net margin N/C N/C N/C -2333.6% -50.4% N/C N/C N/C

Revenue and income statement

In 2024, INNOPROD MEDICAL records a net loss of 173 k€. This deficit will reduce equity on the balance sheet.

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

-19 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-147 258 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-97 478 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-172 697 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at -936%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -11%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-935.7%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-11.436%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-6.801

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

52.4%

Solvency indicators evolution
INNOPROD MEDICAL

Sector positioning

Debt ratio
-935.7 2024
2022
2023
2024
Q1: 1.92
Med: 18.86
Q3: 55.42
Excellent -54 pts over 3 years

In 2024, the debt ratio of INNOPROD MEDICAL (-935.70) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-11.44% 2024
2022
2023
2024
Q1: 24.8%
Med: 50.27%
Q3: 69.09%
Average

In 2024, the financial autonomy of INNOPROD MEDICAL (-11.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-6.8 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.3 years
Q3: 1.74 years
Excellent

In 2024, the repayment capacity of INNOPROD MEDICAL (-6.80) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 381.55. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

381.551

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-51.08

Liquidity indicators evolution
INNOPROD MEDICAL

Sector positioning

Liquidity ratio
381.55 2024
2022
2023
2024
Q1: 159.64
Med: 253.69
Q3: 429.69
Good +25 pts over 3 years

In 2024, the liquidity ratio of INNOPROD MEDICAL (381.55) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-51.08x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.67x
Q3: 4.96x
Watch

In 2024, the interest coverage of INNOPROD MEDICAL (-51.1x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 123 days. Excellent situation: suppliers finance 123 days of the operating cycle (retail model).

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

123 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
INNOPROD MEDICAL

Positioning of INNOPROD MEDICAL in its sector

Comparison with sector Fabrication de matériel médico-chirurgical et dentaire

Similar companies (Fabrication de matériel médico-chirurgical et dentaire)

Compare INNOPROD MEDICAL with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire

Frequently asked questions about INNOPROD MEDICAL

What is the revenue of INNOPROD MEDICAL ?

The revenue of INNOPROD MEDICAL in 2021 is 2 k€.

Is INNOPROD MEDICAL profitable?

INNOPROD MEDICAL recorded a net loss in 2024.

Where is the headquarters of INNOPROD MEDICAL ?

The headquarters of INNOPROD MEDICAL is located in PLAISANCE-DU-TOUCH (31830), in the department Haute-Garonne.

Where to find the tax return of INNOPROD MEDICAL ?

The tax return of INNOPROD MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does INNOPROD MEDICAL operate?

INNOPROD MEDICAL operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.